ALK and peripheral T-cell lymphoma, not otherwise specified: Recent studies reported TP53 mutations in 16% of systemic ALCL (11% ALK+, 23% ALK-negative) and 15% of peripheral T cell lymphomas (including ALCL cases); in addition, TP53 mutation was associated with a poor prognosis [37,38].